TAICEND TECHNOLOGY CO., LTD

TAICEND TECHNOLOGY is a Taiwanese medical device manufacturer established in the Kaohsiung Science Park, specializing in innovative wound care and healing solutions. The company combines biotechnology, clinical medicine, and advanced material technology to develop products that address various wound healing stages. TAICEND's product portfolio encompasses sterile waterproof foam dressings with anti-adhesion properties (Stage 1), surgical hydrogel patches (Stage 2), scar care dressings (Stage 3), skin barrier films, pressure relief pads, and dermatological care products. Products are designed through collaboration between biomedical researchers, materials scientists, and clinical practitioners to ensure efficacy and clinical applicability. The company conducts biomedical validation and clinical evidence gathering to support product safety and performance. TAICEND serves clinical and consumer markets with both sterile and non-sterile wound management solutions. While the fetched content does not explicitly state FDA approval or specific regulatory certifications, the company's emphasis on clinical validation and biomedical testing suggests alignment with medical device regulatory frameworks. Products are marketed under the TAICEND brand and sold through multiple distribution channels including online platforms.